hotspot -WSS

hotspot

author：comprehensive 2025-10-02 00:52:35 - browse：922

Anna Yeo/STAT

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?

In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.

Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Intarcia’s device

leisure time

WSS

Lasker Awards 2023: Winners in biomedical research

Emergency workers more likely to restrain Black patients: study

FDA panel to weigh approval of NurOwn, controversial ALS drug

FDA proposes changes to key medical devices approval pathway

CDC advisers recommend seasonal use of Pfizer RSV shot

How medical schools plan to diversify without affirmative action

hotspot

hotspot

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How AI helped researchers track recovery from depression

Alkermes shareholders re

Intarcia’s device

Medical records are filled with copy

EpiPen alternative approval delay highlights citizen petition issue

Tori Bowie and the unacceptable rates of Black maternal death

New Covid vaccine is recommended for everyone 6 months or older

Medicare proposal to cover medical devices draws a mixed reaction

Biotech lab space demand falls sharply

focus

Will the IRA bring competition to the biologics market?

New Covid vaccine is recommended for everyone 6 months or older

How housing is health care on Long Island

Will the IRA bring competition to the biologics market?

Generate Biomedicines machine learning biotech raises $273M

Second xenotransplant done with gene

hotspot

hotspot

focus

explore